Home The Word Brain My Amedeo FAQ Privacy About


Hanzi Hunter

Learning 500 Chinese characters in 30 days is possible.

Abstract • About

  Tuberculosis

  Free Subscription


Articles published in PLoS Med

Retrieve available abstracts of 27 articles:
HTML format



Single Articles


    February 2026
  1. PORTNOY A, Clark RA, Jit M, McQuaid CF, et al
    The potential impact of reduced international donor funding on the household economic burden of tuberculosis in low- and middle-income countries: A modeling study.
    PLoS Med. 2026;23:e1004946.
    PubMed     Abstract available


  2. TANVIR H, Clark RA, Sumner T, Horton KC, et al
    Estimating the population impact of new tuberculosis vaccines depending on efficacy against infectious asymptomatic tuberculosis: A modelling study.
    PLoS Med. 2026;23:e1004595.
    PubMed     Abstract available


  3. SCHWALB A, Dodd PJ, Rickman HM, Ugarte-Gil CA, et al
    Estimating the global burden of viable Mycobacterium tuberculosis infection: A mathematical modelling study.
    PLoS Med. 2026;23:e1004920.
    PubMed     Abstract available


  4. DUROVNI B, Cordeiro-Santos M, Cavalcante SC, Spener-Gomes R, et al
    Acceptability and safety of one versus three months of rifapentine and isoniazid to prevent tuberculosis in people exposed in the household or workplace in Brazil: The Ultra-Curto randomized controlled trial.
    PLoS Med. 2026;23:e1004758.
    PubMed     Abstract available


    November 2025
  5. HEITKAMP P, Chijioke-Akaniro O, Pai M
    From dependence to self-reliance: The future of the global tuberculosis response.
    PLoS Med. 2025;22:e1004824.
    PubMed     Abstract available


  6. OLBRICH L, Larsson L, Dunbar R, Dodd PJ, et al
    Diagnostic accuracy of the WHO tuberculosis treatment decision algorithms for children with presumptive tuberculosis: An individual participant data meta-analysis.
    PLoS Med. 2025;22:e1004610.
    PubMed     Abstract available


    July 2025
  7. ADJOBIMEY M, Trajman A, Bastos ML, Valiquette C, et al
    Rapid molecular testing or chest X-ray or tuberculin skin testing for household contact assessment of tuberculosis infection: A cluster-randomized trial.
    PLoS Med. 2025;22:e1004666.
    PubMed     Abstract available


    May 2025
  8. HSIEH YL, Horsburgh CR Jr, Cohen T, Miller JW, et al
    Cost-effectiveness of screening with transcriptional signatures for incipient TB among U.S. migrants.
    PLoS Med. 2025;22:e1004603.
    PubMed     Abstract available


    January 2025
  9. KIM S, Can MH, Agizew TB, Auld AF, et al
    Factors associated with tuberculosis treatment initiation among bacteriologically negative individuals evaluated for tuberculosis: An individual patient data meta-analysis.
    PLoS Med. 2025;22:e1004502.
    PubMed     Abstract available


    December 2024
  10. KEOGH-BROWN MR, Sumner T, Sweeney S, Vassall A, et al
    Estimating the health and macroeconomic burdens of tuberculosis in India, 2021-2040: A fully integrated modelling study.
    PLoS Med. 2024;21:e1004491.
    PubMed     Abstract available


    November 2024
  11. MACPHERSON P, Stagg HR, Schwalb A, Henderson H, et al
    Impact of active case finding for tuberculosis with mass chest X-ray screening in Glasgow, Scotland, 1950-1963: An epidemiological analysis of historical data.
    PLoS Med. 2024;21:e1004448.
    PubMed     Abstract available


    September 2024
  12. CALDERWOOD CJ, Marambire ET, Larsson L, Banze D, et al
    HIV, malnutrition, and noncommunicable disease epidemics among tuberculosis-affected households in east and southern Africa: A cross-sectional analysis of the ERASE-TB cohort.
    PLoS Med. 2024;21:e1004452.
    PubMed     Abstract available


    July 2024
  13. BURMAN W, Rucsineanu O, Horsburgh CR, Johnston J, et al
    Research on the treatment of rifampin-susceptible tuberculosis-Time for a new approach.
    PLoS Med. 2024;21:e1004438.
    PubMed     Abstract available


    May 2024
  14. JHAVERI TA, Jhaveri D, Galivanche A, Lubeck-Schricker M, et al
    Barriers to engagement in the care cascade for tuberculosis disease in India: A systematic review of quantitative studies.
    PLoS Med. 2024;21:e1004409.
    PubMed     Abstract available


  15. JAMES LP, Klaassen F, Sweeney S, Furin J, et al
    Impact and cost-effectiveness of the 6-month BPaLM regimen for rifampicin-resistant tuberculosis in Moldova: A mathematical modeling analysis.
    PLoS Med. 2024;21:e1004401.
    PubMed     Abstract available


  16. TELISINGHE L, Floyd S, MacLeod D, Schaap A, et al
    Incidence of self-reported tuberculosis treatment with community-wide universal testing and treatment for HIV and tuberculosis screening in Zambia and South Africa: A planned analysis of the HPTN 071 (PopART) cluster-randomised trial.
    PLoS Med. 2024;21:e1004393.
    PubMed     Abstract available


    April 2024
  17. CHEN L, Xing Y, Zhang Y, Xie J, et al
    Long-term variations of urban-Rural disparities in infectious disease burden of over 8.44 million children, adolescents, and youth in China from 2013 to 2021: An observational study.
    PLoS Med. 2024;21:e1004374.
    PubMed     Abstract available


    March 2024
  18. EMANI S, Alves K, Alves LC, da Silva DA, et al
    Quantifying gaps in the tuberculosis care cascade in Brazil: A mathematical model study using national program data.
    PLoS Med. 2024;21:e1004361.
    PubMed     Abstract available


    February 2024
  19. SEMITALA FC, Kadota JL, Musinguzi A, Welishe F, et al
    Comparison of 3 optimized delivery strategies for completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV in Uganda: A single-center randomized trial.
    PLoS Med. 2024;21:e1004356.
    PubMed     Abstract available


    November 2023
  20. GALILEYA LT, Wasmann RE, Chabala C, Rabie H, et al
    Evaluating pediatric tuberculosis dosing guidelines: A model-based individual data pooled analysis.
    PLoS Med. 2023;20:e1004303.
    PubMed     Abstract available


    October 2023
  21. NARAYAN A, Salindri AD, Keshavjee S, Muyoyeta M, et al
    Prioritizing persons deprived of liberty in global guidelines for tuberculosis preventive treatment.
    PLoS Med. 2023;20:e1004288.
    PubMed     Abstract available


    September 2023
  22. MAFIRAKUREVA N, Mukherjee S, de Souza M, Kelly-Cirino C, et al
    Cost-effectiveness analysis of interventions to improve diagnosis and preventive therapy for paediatric tuberculosis in 9 sub-Saharan African countries: A modelling study.
    PLoS Med. 2023;20:e1004285.
    PubMed     Abstract available


  23. KLINKENBERG E, Floyd S, Shanaube K, Mureithi L, et al
    Tuberculosis prevalence after 4 years of population-wide systematic TB symptom screening and universal testing and treatment for HIV in the HPTN 071 (PopART) community-randomised trial in Zambia and South Africa: A cross-sectional survey (TREATS).
    PLoS Med. 2023;20:e1004278.
    PubMed     Abstract available


    July 2023
  24. PORTNOY A, Arcand JL, Clark RA, Weerasuriya CK, et al
    The potential impact of novel tuberculosis vaccine introduction on economic growth in low- and middle-income countries: A modeling study.
    PLoS Med. 2023;20:e1004252.
    PubMed     Abstract available


    June 2023
  25. DORVIL N, Rivera VR, Riviere C, Berman R, et al
    Same-day testing with initiation of antiretroviral therapy or tuberculosis treatment versus standard care for persons presenting with tuberculosis symptoms at HIV diagnosis: A randomized open-label trial from Haiti.
    PLoS Med. 2023;20:e1004246.
    PubMed     Abstract available


    May 2023
  26. MARTINSON NA, Nonyane BAS, Genade LP, Berhanu RH, et al
    Evaluating systematic targeted universal testing for tuberculosis in primary care clinics of South Africa: A cluster-randomized trial (The TUTT Trial).
    PLoS Med. 2023;20:e1004237.
    PubMed     Abstract available


  27. BALIASHVILI D, Blumberg HM, Gandhi NR, Averhoff F, et al
    Hepatitis C care cascade among patients with and without tuberculosis: Nationwide observational cohort study in the country of Georgia, 2015-2020.
    PLoS Med. 2023;20:e1004121.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum